Haemonetics | HAE - Umsatzkosten

Aktienkurs
58.58
Täglich Wechseln
-0.32 -0.54%
Monatlich
-4.42%
Jährlich
-8.47%
Q1 Prognose
56.82




Umsatzkosten Veränderung Datum
Avanos Medical USD 94.9M 3.1M 2025-12
Baxter International USD 2.4B 512M 2025-12
Becton, Dickinson and Co. USD 2.84B 2.35B 2025-12
Boston Scientific USD 1.84B 82M 2025-12
Cerus USD 23.42M 3.61M 2024-12
Cooper Companies USD 376.8M 87.4M 2025-12
Fresenius EUR 4.45B 262M 2025-12
Fresenius Medical Care EUR 3.68B 38.37M 2025-12
Globus Medical USD 290.47M 8.09M 2025-12
Haemonetics USD 136.58M 4.01M 2025-12
Hologic USD 463.7M 5.1M 2025-12
ICU Medical USD 337.72M 1.61M 2025-12
Intuitive Surgical USD 961.9M 119.2M 2025-12
Masimo USD 165.2M 24.3M 2025-12
Medtronic USD 3.61B 83M 2025-12
Merit Medical Systems USD 198.58M 838K 2025-12
Neogen USD 118.01M 3.79M 2025-09
OraSure Technologies USD 15.43M 113K 2025-12
Quidel USD 448.8M 1.21B 2025-12
ResMed USD 555.85M 29.13M 2025-12
STAAR Surgical USD 14.06M 2.8M 2025-12
Steris USD 840.7M 26.3M 2025-12
Stryker USD 2.69B 373M 2025-12
Surmodics USD 33.03M 24.58M 2024-09
Teleflex USD 261.54M 199.84M 2025-12
Terumo JPY 143.44B 15.47B 2025-12
Thermo Fisher Scientific USD 7.58B 674M 2025-12
US Physical Therapy USD 160.86M 2.63M 2025-12
Zimmer Biomet Holdings USD 970.1M 234.3M 2025-12